Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nesher Pharmaceuticals Inc.

Division of Zydus Cadila

Latest From Cordis Webster Inc.

Hearten Medical Inc.

Hearten Medical Inc. has designed a less-invasive surgical system for repairing cardiac damage caused by heart attacks. The MyoTech Cardiac Restoration System applies heat to the external surface of a beating heart to shrink scar tissue and restore the heart to normal size and function.
Medical Device Innovation

Cardiac Pathways: Mapping a Tough Course in EP

Cardiac Pathways' strategy is to develop solutions for the most difficult cardiac rhythm problems, those for which even palliative treatments are limited. Armed with promising advanced technology, the company was one of the last through the 1996 medical device IPO window but since then has been paying the price for being slow to market. With FDA approval finally in hand, along with new management and additional financing obtained at a premium cost, Cardiac Pathways hopes to sustain itself long enough to finally take advantage of its technological lead by creating a new market treating patients who have few other options.
Medical Device North America
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Zydus Cadila
  • Senior Management
  • Contact Info
  • Nesher Pharmaceuticals Inc.
    Phone: (877) 406-5725
    1 Corporate Woods Dr.
    Bridgeton, MO 63044